SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
822OPi and Vaccinex Announce License of Fully Human Anti-IL6 Antibody Tuesday Octobnigel bates-10/10/2006
821AZN has been licensing some alternatives to MABs ("Darpins" and "nigel bates-10/8/2006
820XOMA does another x-license - Message 22868073 Still think that they will get tnigel bates-10/2/2006
819MorphoSys and U.S. Army Enter into Biodefense Cooperation - MorphoSys's AbD Germanecki-9/25/2006
818Invasion of the Nanobodies Can they crack a $15-billion global market? Septembedr.praveen-9/20/2006
817Have Some Sugar with Your Protein sciam.com IN FOCUS September 07, 2006 Doc Bones-9/10/2006
816GlycoFi and Dartmouth Report Full Humanization of Yeast Glycosylation Pathway innigel bates-9/7/2006
815Cool - thanks. Interesting that Momenta not namechecked.nigel bates-9/6/2006
814Glycosylation Engineering pubs.acs.org Cheers, Praveendr.praveen-9/5/2006
813Ablynx Completes Euro 40 Million (approx. US$50 Million) Series C Financing: Onenigel bates-8/23/2006
812AbD Serotec Opens New U.S. Office in Research Triangle Region August 4, 2006 &Germanecki-8/4/2006
811MorphoSys Q2 results: Tax items led to small net loss, but well on track to deliGermanecki-7/28/2006
810Molecular Partners and Cambridge Antibody Technology Sign Cross-Licence Agreemennigel bates-7/26/2006
809Buckyball-Antibody Combination Delivers Antitumor Drugs Combining a monoclonal Icebrg-7/4/2006
808Morphotek Announces Orphan Drug Status Granted for MORAb-003, A Monoclonal Antibnigel bates-6/21/2006
807Cuba Approves New Monoclonal Antibody Havana, May 31 (Prensa Latina) Cuban healIcebrg-6/3/2006
806Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Offnigel bates-6/1/2006
805EvoGenix Announces Antibody Collaboration with CSL Thursday June 1, 3:21 am ET nigel bates-6/1/2006
804MorphoSys and Schering-Plough Sign R&D Agreement Press Release Martinsried/Germanecki-5/17/2006
803Yes, the biotecs are really not overpaid these days. I hope Astra Zeneca is lookGermanecki-5/15/2006
802£702m - Message 22450709 - though rather less to AZN, as they hold nearlnigel bates-5/15/2006
801Astra Zeneca to swoop on Cambridge drug group Mark Kleinman and Paul Durman TheGermanecki-5/14/2006
800>>but this recent wave is a bit different...<< Not so different ? Mnigel bates-5/14/2006
799Biology Rising Kerry A. Dolan, 05.12.06, 10:00 AM ET Burlingame, Calif. - Itdr.praveen-5/13/2006
798Merck buys Glycofi for $400m Message 22431213nigel bates-5/9/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News